Principal Players in Historic ALS Drug-Search
Collaboration Meet in Boston for Dedication

Lynne Nieto, with her husband and MDA ALS Division co-chair, Augie, cuts the ribbon to commemorate the new Muscular Dystrophy Association and ALS Therapy Development Institute research program. The joint-venture will attempt to identify biochemical targets and find drugs that work on them in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease).

Jamie Heywood and Sean Scott of  the ALS Therapy Development Institute, left, were presented with a dedication plaque by MDA ALS Division co-chairs and Augie's Quest founders Augie and Lynn Nieto.  The $36 million drug discovery collaboration is the largest of its kind in ALS research history.